Stock analysis, trade plans, and proprietary indicators by Trend Edge.
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. Read full Trend Edge analysis →
| Current Price | $16.49 |
|---|---|
| Market Cap | $23.7M |
| Float | 1.4M |
| Shares Outstanding | 1.9M |
| Dividend Rate | None |
| Year | Revenue | Net Income | Gross Profit | EBITDA |
|---|---|---|---|---|
| 2020 | N/A | -$73,000 | -$1,000 | -$72,000 |
| 2021 | N/A | -$711,000 | -$6,000 | -$703,000 |
| 2022 | N/A | -$779,000 | -$5,000 | -$772,000 |
| 2023 | N/A | -$600,000 | -$4,000 | -$631,000 |
| 2024 | N/A | -$1.5M | -$118,000 | -$1.4M |
| 2025 | N/A | -$3.3M | -$342,000 | -$5.9M |
| Quarter | Revenue | Net Income |
|---|---|---|
| Dec 2024 | N/A | -$957,000 |
| Mar 2025 | N/A | -$88.5 |
| Jun 2025 | N/A | -$88.5 |
| Dec 2025 | N/A | -$3.2M |
| Insider Ownership | 1.0% |
|---|---|
| Institutional Ownership | 9.7% |
| Short Float | 2.5% |
| % of All Funds Holding | 0.05% |
| Number of Funds Holding | 4 |
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
| Timeframe | SMA | Value | Trend Context |
|---|---|---|---|
| Weekly | 10-Week SMA | $14.08 | Near-term / short-term trend |
| Weekly | 40-Week SMA | $10.70 | Medium-term trend |
| Weekly | 80-Week SMA | $455.15 | Cyclical trend (business cycle) |
| Weekly | 200-Week SMA | $0.00 | Secular trend (multi-year) |
| Monthly | 10-Month SMA | $9.89 | Near-term monthly trend |
| Monthly | 20-Month SMA | $536.37 | Medium-term monthly trend |
| Monthly | 40-Month SMA | $0.00 | Secular monthly trend |
Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
| Price Level | Type | Volume Ratio | Age |
|---|---|---|---|
| $3.30 | support | 6.65x | 4 months ago |
| Timeframe | Avg Return | Median | Win Rate | Best | Worst |
|---|---|---|---|---|---|
| Gap | 1.24% | 1.24% | 100.00% | 1.96% | 0.53% |
| 1 Day | -2.16% | -2.16% | 50.00% | 1.96% | -6.27% |
| 1 Week | -10.04% | -10.04% | 50.00% | 3.92% | -24.00% |
| 2 Weeks | -15.24% | -15.24% | 50.00% | 6.86% | -37.33% |
| 1 Month | -17.60% | -17.60% | 50.00% | 13.73% | -48.93% |
Next earnings: June 24, 2026 (27 days away)
Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).
Institutional holder breakdown coming soon.
Total institutional ownership: 9.7%
Total insider ownership: 1.0%
Founder-led management: Tomer Izraeli (Chief Executive Officer & Director)
| Total Filings | 6 |
|---|---|
| Net Value | -$80,230.3 |
| Net Shares Change | -11,651 |
| % of Float | -0.8% |
| C-Suite Filings | 3 |
| Clusters Detected | 1 |
| Name | Title | Net Value | Filings | Activity |
|---|---|---|---|---|
| Izraeli Tomer | Chief Executive Officer | -$48,435 | 2 | 2 sell |
| Adler Oz | -$39,668.6 | 1 | 1 sell | |
| Turgeman Tidhar | Chief Technology Officer | -$31,795.3 | 1 | 1 sell |
| Carmel Liron | -$12,743.12 | 2 | 2 sell |
| Period | Filings | Insiders | Net Value | Seniority |
|---|---|---|---|---|
| 2026-03-31 – 2026-04-01 | 6 | 4 | -$132,642.02 | 3 C-suite |
| Date | Insider | Title | Net Value | Price After |
|---|---|---|---|---|
| 2026-03-31 | Turgeman Tidhar | Chief Technology Officer | -$31,795.3 | Transaction at $10.90, now +51.3% |
| 2026-03-31 | Izraeli Tomer | Chief Executive Officer | -$42,510 | Transaction at $10.90, now +51.3% |
| 2026-04-01 | Adler Oz | -$39,668.6 | Transaction at $12.05, now +36.8% | |
| 2026-04-01 | Izraeli Tomer | Chief Executive Officer | -$5,925 | Transaction at $11.85, now +39.2% |
| 2026-04-01 | Carmel Liron | -$11,643.12 | Transaction at $12.36, now +33.4% | |
| 2026-03-31 | Carmel Liron | -$1,100 | Transaction at $11.00, now +49.9% |
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Polyrizon Ltd. Ordinary Shares (PLRZ) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.
Get the full AI Consult analysis for PLRZ on Trend Edge →